Related Experiment Video
Updated: Jan 7, 2026
Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Intermittent fasting improves metabolic outcomes in metabolic syndrome: a systematic review and meta-analysis with
Qian Song1, Alaa Sultan H Almutairi2, Manal Fehaid A Almutairi2
1Department of Osteo-Internal Medicine, Tianjin Hospital, Tianjin University, Tianjin, China.
Background:
Previous studies have demonstrated that intermittent fasting (IF) has garnered scientific attention and gained recognition for its beneficial effects on metabolic outcomes. However, the results are inconsistent. Accordingly, this systematic review and meta-analysis aimed to evaluate the effect of fasting on glycemic control, lipid profile, and inflammatory markers.
Methods:
Databases such as PubMed, Embase, Cochrane, Scopus, and Web of Science were used to retrieve relevant studies published until September 2025. The quality of the included studies was evaluated using the Cochrane Risk-of-Bias 2 (RoB2) tool. Moreover, the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was employed to evaluate the quality of evidence.
Results:
A total of 10 studies, involving 701 individuals, were included in the current meta-analysis. The combined effect of various types of fasting significantly reduced fasting blood sugar (FBS) [standard mean difference (SMD) = -0.51; 95% confidence interval (CI): -0.81, -0.20; p = 0.001], insulin (SMD = -0.27; 95% CI: -0.52, -0.03; p = 0.027) and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (SMD = -0.39; 95% CI: -0.65, -0.12; p = 0.004), and HbA1c (SMD = -0.25; 95% CI: -0.49, -0.02; p = 0.034) levels. Moreover, the regimen successfully exerted its beneficial effect on low-density lipoprotein cholesterol (LDL-C) (SMD = -0.34; 95% CI: -0.53, -0.14; p = 0.001) and interleukin-6 (IL-6) (SMD = -0.30; 95% CI: -0.57, -0.03; p = 0.029) levels as well. The sensitivity analysis indicated that excluding any single study had no effect on the overall effect size (ES) for FBS, blood sugar (BS), HOMA-IR, LDL-C, and high-density lipoprotein cholesterol (HDL-C). Moreover, the results of the GRADE approach scored high quality of evidence for FBS, insulin, HOMA-IR, HbA1c, total cholesterol (TC), LDL-C, and IL-6, which suggests the robustness of the results. No evidence of publication bias was detected using Egger's and Begg's test (p > 0.05).
Conclusion:
The findings suggest that intermittent fasting may have favorable effects on the metabolic panel, specifically, FBS, insulin, HOMA-IR, (HbA1c), LDL-C, and IL-6 levels.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
01:24Metabolic States of the Body: Fasting and Starvation
01:18Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:19Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion